- Home
- ATUS vs ANAB Comparison
ATUS vs ANAB Comparison
Compare ATUS & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATUS
- ANAB
- Stock Information
- Founded
- ATUS 2015
- ANAB 2005
- Country
- ATUS United States
- ANAB United States
- Employees
- ATUS N/A
- ANAB N/A
- Industry
- ATUS Cable & Other Pay Television Services
- ANAB Biotechnology: Pharmaceutical Preparations
- Sector
- ATUS Telecommunications
- ANAB Health Care
- Exchange
- ATUS Nasdaq
- ANAB Nasdaq
- Market Cap
- ATUS 1.0B
- ANAB 1.0B
- IPO Year
- ATUS 2017
- ANAB 2017
- Fundamental
- Price
- ATUS $2.08
- ANAB $38.47
- Analyst Decision
- ATUS Hold
- ANAB Buy
- Analyst Count
- ATUS 5
- ANAB 12
- Target Price
- ATUS $2.75
- ANAB $63.30
- AVG Volume (30 Days)
- ATUS 3.0M
- ANAB 353.6K
- Earning Date
- ATUS 11-06-2025
- ANAB 11-04-2025
- Dividend Yield
- ATUS N/A
- ANAB N/A
- EPS Growth
- ATUS N/A
- ANAB N/A
- EPS
- ATUS N/A
- ANAB N/A
- Revenue
- ATUS $8,642,622,000.00
- ANAB $169,467,000.00
- Revenue This Year
- ATUS N/A
- ANAB $37.52
- Revenue Next Year
- ATUS N/A
- ANAB N/A
- P/E Ratio
- ATUS N/A
- ANAB N/A
- Revenue Growth
- ATUS N/A
- ANAB 196.42
- 52 Week Low
- ATUS $1.95
- ANAB $12.21
- 52 Week High
- ATUS $3.20
- ANAB $40.87
- Technical
- Relative Strength Index (RSI)
- ATUS 36.66
- ANAB 72.78
- Support Level
- ATUS $2.05
- ANAB $34.22
- Resistance Level
- ATUS $2.19
- ANAB $37.08
- Average True Range (ATR)
- ATUS 0.12
- ANAB 2.03
- MACD
- ATUS -0.01
- ANAB -0.18
- Stochastic Oscillator
- ATUS 30.70
- ANAB 68.07
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).